We previously demonstrated that c-Jun N-terminal kinase (JNK) phosphorylates serine 62 of BclxL to induce the degradation of Bcl-xL and apoptosis in WEHI-231 cells upon BCR crosslinking. In order to elucidate the regulatory mechanisms underlying the phosphorylation of Bcl-xL, we prepared an assay system in which JNK phosphorylated Bcl-xL in HEK293T cells. Consequently, we found that a signal transduction molecule, alpha4, enhanced the phosphorylation of Bcl-xL by JNK, while the co-expression of C-terminal alpha4 (220-340) diminished the phosphorylation of Bcl-xL induced by JNK. Furthermore, full-length alpha4 associated with both JNK and Bcl-xL, whereas C-terminal alpha4 (220-340) associated only with Bcl-xL, not JNK. In addition, WEHI-231 cells transfected with the cDNA of C-terminal alpha4 (220-340) exhibited decreased phosphorylation of Bcl-xL and stronger resistance to apoptosis induced by BCR crosslinking. These results indicate that alpha4 is an important regulatory molecule of apoptosis induced by BCR crosslinking in WEHI-231 cells and that C-terminal alpha4 (220-340) functions as a dominant negative form.
B cell receptor (BCR) signaling induces the proliferation of mature B cells while simultaneously stimulating immature B cells toward apoptosis (5) . Self-reactive B cells with BCR, which have high affinity for self-antigens, are eliminated at the immature B cell stage (10) . However, the mechanisms regulating this process remain elusive. The WEHI-231 cell line has been extensively used as a model to study the regulation of apoptosis in immature B cells induced by BCR crosslinking (15) . The stimulation by anti-IgM antibody (Ab), which mimics antigen stimulation, induces apoptosis in WEHI-231 cells, and Bcl-xL plays an important role in the BCR crosslinking-induced apoptosis of these cells (15, 21) .
Cellular apoptosis is controlled by Bcl-2 family proteins. Bcl-2 family members include two groups (21) : one group consisting of Bcl-2, Bcl-xL and other proteins that support cell survival and one group containing Bax and Bak, both of which have proapoptotic activities. Bcl-xL and Bcl-2 appear to function in the same apoptotic pathway and are especially important for controlling apoptosis in lymphocytes (20) . The overexpression of either molecule confers resistance in the setting of BCR-induced apoptosis in WEHI-231 cells (4) . Moreover, Bcl-xL heterodimerizes with proapoptotic molecules, thus suppressing their activity, while the phosphorylation of serine 62 (Ser62) of Bcl-xL abolishes this anti-apoptotic effect. We previously reported that BCR crosslinking induces Ser62 phosphorylation by c-Jun N-terminal kinase (JNK) and the subsequent degradation of Bcl-xL via the ubiquitin proteasome pathway in WEHI-231 cells (9) . JNK belongs to the mitogen-activated protein kinase (MAPK) family and is an important factor in the stress-induced apoptosis mediated by the mito-land, NY) supplemented with 8% heat-inactivated fetal bovine serum, 100 IU/mL of penicillin, 100 μg/mL of streptomycin and 50 μM of 2-mercaptoethanol.
Reagents and antibodies. Anti-FLAG M2 antibody (Ab) (Stratagene, La Jolla, CA), anti-HA 3F10 Ab (Roche, Basel, Switzerland) and anti-Bcl-xL (pS62) phosphospecific polyclonal Ab (Millipore, Bedford, MA) were purchased for the Western blot and/or immunoprecipitation studies. Anti-IgM mAb M41 was a kind gift from Dr. Rolink at the University of Basel (Basel, Switzerland). MG-132 was purchased from Millipore, and okadaic acid (OA) was purchased from Wako Chemical Industries (Osaka, Japan).
Plasmids. The preparation and subcloning of FLAGtagged Bcl-xL cDNA into the expression vector is described in a previous study (9) . The characteristics of alpha4 cDNA have been previously described (7), and alpha4 cDNA was subcloned into the pcDNA-HA vector. Human JNK1 and JNK2 cDNAs were a kind gift from Dr. Ogata at Mie University in Japan. The cDNA of C-terminal alpha4 (220-340) was prepared via PCR using the primers 5'-GGGGATCCG AAAGAGACTCTTCAAGA-3' and 5'-GGGAAT TCTCAGCCCATGTTCTGTCGGTT-3'.
Transfection. In order to establish WEHI-Bcl-xL cells stably expressing C-terminal alpha4 (220-340), cells were transfected via electroporation using a Gene Pulser II (Bio-Rad, Hercules, CA). Linearized C-terminal alpha4 (220-340) plasmid, with pTRE2pur plasmid (TaKaRa Bio, Shiga, Japan) as a selectable marker, was transfected simultaneously. Following selection with puromycin for 2 weeks, individual clones were obtained by limiting dilution. The transient transfection of HEK293T cells was performed using HilyMax transfection reagent (Dojindo, Kumamoto, Japan), according to the manufacturer's protocol. For detection of the phosphorylation of Bcl-xL by JNK in the HEK293T cells, 50 nM of OA was added for the last 4 h of culture.
Immunoprecipitation and Western blot analysis.
The immunoprecipitation and Western blot analyses were performed as previously described (9) . Lysis buffer (25 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM DTT, 1 mM EDTA, 15 mM NaPPi, 100 mM β-glycerophosphate, 25 mM NaF, 0.05% NaN 3 , 100 μM Na 3 VO 4 , 0.5% CHAPS) with a phosphatase inhibitor cocktail (Nacalai tesque, Kyoto, Japan) was used for the analysis of the co-immunoprecipitation of alpha4 with other molecules and the detection of chondrial pathway (2) . In addition, JNK-deficient cells show severe impairment under conditions of stress-induced apoptosis (2), and JNK is especially important in the induction of apoptosis in lymphocytes (14) . However, it remains to be determined precisely how JNK induces apoptosis; JNK activation may cause apoptosis via both transcriptiondependent and -independent mechanisms (2). One proposed mechanism of transcription-independent control is that JNK phosphorylates Bcl-2 family members, thereby regulating apoptosis (2). We previously showed that BCR crosslinking induces the sustained activation of JNK in WEHI-231 cells (9) . In the present study, we developed an assay system to investigate the regulatory mechanisms underlying the phosphorylation of Bcl-xL. The results consequently showed that JNK phosphorylates Bcl-xL in HEK293T cells. Alpha4 was originally identified as a component of the BCR complex (6) . The amino acid sequence of alpha4 is highly conserved among mammalian species (13) , and a subsequent study revealed that alpha4 associates with the catalytic subunits of protein phosphatase (PP) 2A, PP4 and PP6 (1, 7) . Notably, alpha4 regulates the enzymatic activity of PP2A and PP6 (7). Furthermore, the yeast homolog of PP6, Sit4, functions as a cell cycle regulator (19) , and human PP6 has been shown to be an apoptosisrelated molecule involved in tumor development (12) . We also previously demonstrated that PP6 regulates TNF-induced apoptosis in HeLa cells by dephosphorylating serine 10 of p27 (8) . In addition, gene targeting experiments have shown that the deletion of alpha4 leads to cell death (11) . The present findings demonstrate for the first time that alpha4 enhances the phosphorylation of Bcl-xL and that Cterminal alpha4 (220-340) functions as a dominant negative form. This report also shows that alpha4 functions as a regulator of the phosphorylation of Bcl-xL and apoptosis induced by BCR crosslinking in an immature B cell line WEHI-231.
MATERIALS AND METHODS
Cells. The characteristics of the WEHI-231 cell line have been described previously (16) , and the HEK293T cell line was a kind gift from Dr. Kaisho at Wakayama Medical University in Japan. The establishment of a WEHI-231 transfectant expressing FLAG-tagged Bcl-xL cDNA (WEHI-Bcl-xL) has also been previously described (9) . The cells were maintained at 37°C with 5% CO 2 in Iscove's Modified Dulbecco's Medium (GIBCO Laboratories, Grand Is-Statistical analysis. The data are presented as the mean ± SE. Student's t-test was used to calculate the P values. Differences were considered to be significant at a level of 5%.
RESULTS
In order to elucidate the mechanisms underlying the regulation of Bcl-xL phosphorylation by JNK, we prepared an assay system in which the cDNAs of JNK and Bcl-xL were transfected into HEK293T cells. In the presence of JNK, Ser62 of Bcl-xL was phosphorylated in the HEK293T cells (Fig. 1A, left  panel) . The phosphorylation of Bcl-xL was confirmed to be mediated by JNK, as the addition of a JNK inhibitor, SP600125, abrogated this effect (data not shown). We previously showed that PP6 negatively regulates the phosphorylation of Bcl-xL in Ser62 phosphorylation of Bcl-xL. Furthermore, for detection of the phosphorylation of Bcl-xL in the WEHI-231 transfectants, 10 μM of MG-132 and 50 nM of OA were added. X-ray films of the Western blots were scanned and quantified with an Image Freezer densitometer using the CS Analyzer 2.0 software program (Atto, Tokyo, Japan). The lysates were prepared after 24 h of transfection and subjected to a Western blot analysis with anti-pSer62 specific Ab. The membrane was reblotted with anti-FLAG Ab to detect the total amount of FLAG-tagged Bcl-xL, and the effects of the co-transfection of full-length or C-terminal alpha4 (220-340) cDNA were examined as indicated. Densitometry of the phospho-Ser62-Bcl-xL band, normalized to that of total Bcl-xL, was determined, and the fold increase in the presence of full-length or C-terminal alpha4 (220-340) is expressed as the mean ± SE. Full-length alpha4 = 1.88 ± 0.63; C-terminal alpha4 (220-340) = 0.495 ± 0.085 (P < 0.05 for both cases, n = 4). The presence of transfected JNK1/2 and full-length alpha4 or C-terminal alpha4 (220-340) was confirmed using a Western blot analysis. (B) The alignment of the C-terminal amino acids of human, mouse and rat alpha4s is shown (13) . Identical amino acids are highlighted.
Cell viability assay.
phosphorylation of Bcl-xL. Consequently, the cotransfection of the cDNA of C-terminal alpha4 (220-340) diminished the phosphorylation of Bcl-xL by JNK (Fig. 1A, right panel) . These results suggest that the C-terminal region (220-340) of alpha4 functions as a dominant negative form. Considering the possibility that alpha4 may associate with JNK or Bcl-xL, we studied the association of alpha4 with JNK and Bcl-xL using a coimmunoprecipitation assay in the HEK293T cells. Full-length alpha4 indeed associated with both JNK and Bcl-xL ( Fig. 2A, left panel) . However, C-terminal alpha4 (220-340) associated only with Bcl-xL, not JNK ( Fig. 2A, right panel) . In order to investigate the mechanism by which C-terminal alpha4 (220-340) functions as a dominant negative form, we next determined whether the co-existence of Cterminal alpha4 (220-340) inhibits the association of alpha4 with Bcl-xL. The cDNA of Bcl-xL was cotransfected with full-length alpha4 cDNA in the WEHI-231 cells following BCR crosslinking (9) . PP6 is composed of the catalytic subunit, PP6c, and regulatory subunits, including PPR1, PPR2 and PPR3 (17) . Another PP6 regulatory molecule, alpha4, is a common regulator of PP2A subfamily members (1, 7), and alpha4 has been shown to be involved in the regulation of apoptosis (7, 11 ). Therefore, we tested the effects of alpha4 on the phosphorylation of Bcl-xL in the HEK293T cells. As a result, the co-transfection of alpha4 cDNA enhanced the phosphorylation of Bcl-xL by JNK (Fig. 1A, left panel) . The amino acid sequences of mammalian alpha4s are highly conserved (13) , and the identity of the C-terminal region (220-340) is particularly high in human, mouse and rat alpha4s (Fig. 1B) . Therefore, we prepared a cDNA for the C-terminal region of alpha4 that spanned the 220th amino acid to the C-terminus (C-terminal alpha4 (220-340)), as described in the Materials and Methods section, and tested the effects of the co-transfection of the cDNA on the presence or absence of the cDNA of C-terminal alpha4 (220-340). As shown in Fig. 2B , the co-transfection of the cDNA of C-terminal alpha4 (220-340) decreased the amount of full-length alpha4 co-precipitated with Bcl-xL. In order to investigate the possible involvement of alpha4 in the regulation of apoptosis induced by BCR crosslinking in WEHI-231 cells, we transfected the C-terminal alpha4 (220-340) cDNA into WEHI-231 cells that also expressed exogenous FLAGtagged Bcl-xL (WEHI-Bcl-xL). The expression of C-terminal alpha4 (220-340) decreased the phosphorylation of Bcl-xL induced by BCR crosslinking (Fig. 3A) , and conferred stronger resistance to apoptosis induced by BCR crosslinking in the WEHIBcl-xL cells (Fig. 3B ). These results demonstrate that alpha4 is an important factor in the regulation of apoptosis induced by BCR crosslinking and that C-terminal alpha4 (220-340) functions as a dominant negative form.
DISCUSSION
This paper is the first report to demonstrate that alpha4 regulates the phosphorylation of Bcl-xL by JNK and that the C-terminal region of alpha4 functions as a dominant negative form to suppress the apoptosis induced by BCR crosslinking in WEHI-231 cells. Our findings also showed that alpha4 regulates the activity of JNK toward Bcl-xL. However, it was not determined whether alpha4 acts directly on JNK. JNK does not phosphorylate Bcl-xL in vitro (3), suggesting that other molecules are required for its effects on Bcl-xL. The activity of JNK is tightly regulated by upstream kinases, including MKK4/7 and MKKKs, such as ASK1 and TAK1 (2), and PP2C and PP6 regulate the MKKK-MKK-JNK pathway by dephosphorylating ASK1 and TAK1, respectively (18) . Therefore, the elucidation of the mechanism by which alpha4 regulates the JNK activity necessitates further investigation. The C-terminal region of mammalian alpha4s is highly conserved, with the last 21 amino acids, in particular, being identical among species (13) . The current results showed that C-terminal alpha4 (220-340) functions as a dominant negative form. Furthermore, C-terminal alpha4 (220-340) was shown to associate only with Bcl-xL, not JNK, while fulllength alpha4 associated with both Bcl-xL and JNK. This may be why C-terminal alpha4 (220-340) functions as a dominant negative form by sequestering the substrate Bcl-xL from the enzyme JNK. This assumption was further confirmed by the results showing that the co-expression of C-terminal alpha4 (220-340) inhibited the association between fulllength alpha4 and Bcl-xL. A previous report demonstrated that alpha4 deficiency results in apoptosis and that alpha4 does not associate with either JNK or Bcl-xL (11) . The difference between the present results and those of the previous study may be explained by the differences in the cells employed for the experiments and/or the fact that we used a different type of detergent suitable for detecting associations between proteins. The Ab for 1 h and the lysates were blotted with anti-pSer62 specific Ab. The membrane was reblotted with anti-FLAG Ab to detect the total amount of FLAG-tagged Bcl-xL. The presence of transfected C-terminal alpha4 (220-340) was confirmed using a Western blot analysis. Results are representative of three independent experiments. (B) The same transfectants were stimulated with anti-IgM Ab for 48 h and the cell survival rate was determined using a Cell counting kit-8, as described in the Materials and Methods section. The value of the untreated cells was defined as 100%. Representative results of four independent experiments are shown (P < 0.05, n = 4).
phosphatase inhibitors included in the lysis buffer in the present study may have also helped to maintain the associations between alpha4 and other molecules. We established a WEHI-231 transfectant expressing C-terminal alpha4 (220-340) that became more resistant to apoptosis induced by BCR crosslinking. The increased resistance to apoptosis induced by the C-terminal alpha4 transfection was not conspicuous (Fig. 3B) ; therefore, other regulatory molecules may also control the phosphorylation of Bcl-xL by JNK, which may provide a new direction for future investigations. Our attempt to obtain a WEHI-231 transfectant that expresses full-length alpha4 was unsuccessful, although we applied the transfection several times. Hence, the overexpression of full-length alpha4 may be lethal to WEHI-231 cells, as it may confer sensitivity to apoptosis.
